---
title: Use of Automated Office Blood Pressure Monitoring
nct_id: NCT05395403
overall_status: COMPLETED
phase: NA
sponsor: University of Alabama at Birmingham
study_type: INTERVENTIONAL
primary_condition: Hypertension
countries: United States
canonical_url: "https://parkinsonspathways.com/agent/trials/NCT05395403.md"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT05395403"
ct_last_update_post_date: 2022-05-27
last_seen_at: "2026-05-12T06:16:30.085Z"
source: ClinicalTrials.gov (mirrored, no enrichment)
---
# Use of Automated Office Blood Pressure Monitoring

**Official Title:** Use of Automated Office Blood Pressure Monitoring in Older Working-age Adults

**NCT ID:** [NCT05395403](https://clinicaltrials.gov/study/NCT05395403)

## Key Facts

- **Status:** COMPLETED
- **Phase:** NA
- **Study Type:** INTERVENTIONAL
- **Target Enrollment:** 28
- **Lead Sponsor:** University of Alabama at Birmingham
- **Collaborators:** Troy University
- **Conditions:** Hypertension, Uncontrolled Hypertension, Hypertension, White Coat, Hypertension, Resistant to Conventional Therapy
- **Start Date:** 2021-03-05
- **Completion Date:** 2021-07-05
- **CT.gov Last Update:** 2022-05-27

## Brief Summary

Blood pressure measurements by three methods Office Blood Pressure Measurement (OBPM), Automated Office Blood Pressure Measurement (AOBPM), and Home Blood Pressure Measurement (HBPM) were collected retrospectively across three visits for patients (N=28) referred to a specialty hypertension (HTN) clinic. Demographic data were analyzed using summary statistics. The differences between AOBPM, HBPM, and OBPM were examined using mixed models repeated measures analysis for time and method for each visit.

## Eligibility

- **Minimum age:** 19 Years
- **Sex:** ALL
- **Healthy Volunteers:** No

```
Inclusion Criteria:

* 19 years and older
* Uncontrolled BP
* Prescribed three or more antihypertensive medications at the time of referral
* Higher risk for poor CV outcomes than patients with essential HTN
* OBPM systolic BP of greater than 140 mmHg and diastolic BP of greater than or equal to 90 mm Hg upon initial clinic assessment.

Exclusion Criteria:

* Less than 19 years old
* Had a systolic BP of less than 140 mm Hg and diastolic BP of less than 90 mmHg upon initial clinic assessment.
* Also, patients on less than three antihypertensive medications, with less than three visits, and who have controlled OBPM were excluded.
```

## Arms

- **Office Blood Pressure Measurement (OBPM)** (EXPERIMENTAL) — Traditional office blood pressure monitoring in the primary care clinical environment.
- **Automated Office Blood Pressure Measurement (AOBPM)** (EXPERIMENTAL) — Blood pressure measurement using a validated BpTRU device
- **Home Blood Pressure Measurement (HBPM)** (EXPERIMENTAL) — Blood pressure measurement at patient's home using home monitoring device.

## Interventions

- **Blood pressure measurement device** (DEVICE) — The use of three different devices: traditional office blood pressure measurement cuff (OBPM), automated office blood pressure measurement cuff (AOBPM), and home blood pressure measurement cuff (HBPM).

## Primary Outcomes

- **Number of participants using Traditional office blood pressure measurement (OBPM)** _(time frame: Baseline)_ — Blood pressure control: Traditional office blood pressure measurement less than 140/90 mm Hg
- **Number of participants using Traditional office blood pressure measurement (OBPM)** _(time frame: Up to 8 weeks)_ — Blood pressure control: Traditional office blood pressure measurement less than 140/90 mm Hg
- **Number of participants using Traditional office blood pressure measurement (OBPM)** _(time frame: Up to 16 weeks)_ — Blood pressure control: Traditional office blood pressure measurement less than 140/90 mm Hg
- **Number of participants using Automated office blood pressure measurement (AOBPM)** _(time frame: Baseline)_ — Blood pressure control: Automated office blood pressure measurement less than 130/80 mm Hg
- **Number of participants using Automated office blood pressure measurement (AOBPM)** _(time frame: Up to 8 weeks)_ — Blood pressure control: Automated office blood pressure measurement less than 130/80 mm Hg
- **Number of participants using Automated office blood pressure measurement (AOBPM)** _(time frame: Up to 16 weeks)_ — Blood pressure control: Automated office blood pressure measurement less than 130/80 mm Hg
- **Number of participants using Home blood pressure measurement (HBPM)** _(time frame: Baseline)_ — Blood pressure control: Home blood pressure measurement less than 130/80 mm Hg
- **Number of participants using Home blood pressure measurement (HBPM)** _(time frame: Up to 8 weeks)_ — Blood pressure control: Home blood pressure measurement less than 130/80 mm Hg
- **Number of participants using Home blood pressure measurement (HBPM)** _(time frame: Up to 16 weeks)_ — Blood pressure control: Home blood pressure measurement less than 130/80 mm Hg

## Locations (1)

- University of Alabama at Birmingham, Birmingham, Alabama, United States

## Recent Field Changes (last 30 days)

- `sponsor.lead` — added _(2026-05-12)_
- `sponsor.collaborators` — added _(2026-05-12)_
- `results.hasResults` — added _(2026-05-12)_
- `locations.university of alabama at birmingham|birmingham|alabama|united states` — added _(2026-05-12)_
- `status.overallStatus` — added _(2026-05-12)_
- `status.primaryCompletionDate` — added _(2026-05-12)_
- `status.completionDate` — added _(2026-05-12)_
- `status.lastUpdatePostDate` — added _(2026-05-12)_
- `design.phases` — added _(2026-05-12)_
- `design.enrollmentCount` — added _(2026-05-12)_
- `eligibility.criteria` — added _(2026-05-12)_
- `eligibility.minAge` — added _(2026-05-12)_
- `eligibility.sex` — added _(2026-05-12)_
- `outcomes.primary` — added _(2026-05-12)_
- `armsInterventions.arms` — added _(2026-05-12)_
- `armsInterventions.interventions` — added _(2026-05-12)_

---

*Canonical: https://parkinsonspathways.com/agent/trials/NCT05395403.md*  
*Source data (authoritative): https://clinicaltrials.gov/study/NCT05395403*  
*This page is a raw mirror with no AI summary, no editorial enrichment, and no Parkinson's-specific filtering.*